Love Pharma’s Acquisition Will Offer Exclusive Partnership and License with World Renowned University to Conduct Landmark Psilocybin Study
30 nov. 2021 08h50 HE | Love Pharma Inc.
NEW YORK, NY, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV) (FSE: G1Q0) continues to prioritize the necessity for clinical validation as a vital step in bringing its products to...
W2Email Logo.jpg
Way2Grow (W2G) Biopharma Corp. Receives Health Canada Approval Notice for Construction of a Controlled Substances Dealer’s Licence Level 8 Psychedelic Secure Environ and Psilocybin Production Campus
17 nov. 2021 07h30 HE | Way2Grow Biopharma Corp.
OSOYOOS, British Columbia, Nov. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Way2Grow Biopharma Corp. (“W2G” or the “Company”), a privately held therapeutic corporation existing under the laws...
IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast Featuring Matt Stang, CEO of Delic Holdings Corp.
16 nov. 2021 08h17 HE | InvestorBrandNetwork (IBN)
NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment...
IBN (InvestorBrandNetwork) to Serve as Media Sponsor for the Upcoming Lift&Co. Expo on Nov. 18-21, 2021
10 nov. 2021 09h35 HE | InvestorBrandNetwork (IBN)
NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- IBN (“InvestorBrandNetwork”), an innovative corporate communications firm and content distributor, is pleased to announce today that it will be...
Microdose Psychedelic Insights Provides an Update on the Upcoming Wonderland: Miami Conference, Shares Details on Newly Confirmed Participants and Unmissable Fireside Chats
06 nov. 2021 14h55 HE | Microdose Psychedelic Insights
NEW YORK, Nov. 06, 2021 (GLOBE NEWSWIRE) -- via PsychedlicNewsWire -- Microdose Psychedelic Insights, a cutting-edge media company focused on promoting content, financial analysis and engaging...
LOVE Pharma Announces Debut of New Products, BLOOM™ and AURALIEF™
27 oct. 2021 07h00 HE | Love Pharma Inc.
VANCOUVER, BC CANADA, Oct. 27, 2021 (GLOBE NEWSWIRE) -- LOVE Pharma Co. (CSE: LUV) (FSE: G1Q0), the Company is pleased to announce the debut of its first two products, BLOOM™ and AURALIEF™. ...
Woven Science's El Puente Releases Its Policy Paper on Indigenous Reciprocity & Corporate Social Responsibility
19 oct. 2021 10h00 HE | Woven Science
NEW YORK, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Woven Science's El Puente foundation is pleased to release for public comment its policy paper and corporate social responsibility initiative for...
IBN (InvestorBrandNetwork) and PsychedelicNewsWire to Further Collaborate with Microdose Psychedelic Insights for Upcoming Psychedelic Capital Conference
15 oct. 2021 09h35 HE | InvestorBrandNetwork (IBN)
NEW YORK, Oct. 15, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company, today announces that it will be collaborating with...
Clearmind Medicine Files Provisional Patent Application Related to Methods of Drug-Assisted Psychotherapy
13 oct. 2021 08h00 HE | Clearmind Medicine
TORONTO, Ontario, Oct. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
Love Pharma Makes Public Debut in Emerging Sexual Health, Wellness, and Psychedelics Markets
04 oct. 2021 08h45 HE | Love Pharma Inc.
NEW YORK, NY, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV), formerly Glenbriar Technologies, Inc., is a new-age pharma/nutraceutical company that specializes in the global sexual...